A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : dFLC

Search Conditions:
Search Keyword : dFLC
Search Method : Exact match.
Research Area:

Abbreviation: dFLC
Appearance Frequency: 21 time(s)
Long forms: 8

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
difference between involved and uninvolved free light chains
(11 times)
(8 times)
HR (3 times)
OS (3 times)
AL (2 times)
2016 [Randall-type monoclonal immunoglobulin deposition disease: From diagnosis to treatment].
difference between involved and uninvolved FLC
(3 times)
(1 time)
FLCs (2 times)
FLC (1 time)
iFLC (1 time)
2012 New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes.
difference of free light chain
(2 times)
(2 times)
ASCT (1 time)
R/P (1 time)
VGPR (1 time)
2017 Delineation of the timing of second-line therapy post-autologous stem cell transplant in patients with AL amyloidosis.
amyloidogenic free light chain
(1 time)
(1 time)
ALchemy (1 time)
CKD (1 time)
eGFR (1 time)
2017 Prolonged renal survival in light chain amyloidosis: speed and magnitude of light chain reductionisthe crucial factor.
difference between clonal and nonclonal light-chain
(1 time)
(1 time)
iFLC (1 time)
MGUS (1 time)
SMM (1 time)
2012 Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study.
difference between kappa and lambda free light chain
(1 time)
(1 time)
AL (1 time)
BNP (1 time)
CA (1 time)
2019 Utility of B-Type Natriuretic Peptide for Detecting Cardiac Involvement in Immunoglobulin Amyloidosis.
difference in involved amyloidogenic and uninvolved serum-free light chains
(1 time)
(1 time)
AL (1 time)
CR (1 time)
OS (1 time)
2019 A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib.
differences in serum free light chains
(1 time)
Heart Failure
(1 time)
--- 2019 A Changing Landscape of Mortality for Systemic Light Chain Amyloidosis.